The stock of Divi’s Laboratories Limited surged as much as 5% in the morning trade, at Rs 652 on Monday, in the S&P 100 index.
Further to their earlier communication dated March 22, 2017 to the stock exchanges, Divi’s Laboratories Limited updated that the US-FDA has exempted some more products manufactured at the company's Unit-II at Visakhapatnam from the import alert issued under clauses 66-40 & 99-32 of the FDA regulations.
Divis Laboratories set up its second manufacturing facility at Visakhapatnam (Unit-II). in the year 2002 on a 350 acre site. The site has 14 multi purpose production blocks.
At 10.30 am on Monday, the stock of Divi’s Laboratories Limited was trading at Rs 648, up by Rs 25.55 or 4.10% on the BSE.